Neurodon
  • Home
  • Pipeline
  • Science
  • About
  • News
  • Contact
Press Release

NIH grant to help fast-track Neurodon’s Alzheimer’s drug development research

A $2 million grant from the National Institute on Aging at the National Institutes of…
ZR6WdqV65Y
ZR6WdqV65YAugust 12, 2020
Press Release

New Scientific Advisory Board Member

Neurodon Corporation (https://neurodon.net), a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics…
Colleen Mauger
Colleen MaugerFebruary 17, 2020
Press Release

Neurodon Welcomes Brunde Broady

Neurodon Welcomes Brunde Broady to its Board of Directors Neurodon Corporation announced today the appointment…
Colleen Mauger
Colleen MaugerOctober 3, 2019
Press Release

SERCA Activator May Improve Memory and Cognition for Alzheimer’s Patients

WEST LAFAYETTE, Ind. – A Purdue University graduate and a Purdue Research Park of Northwest…
ZR6WdqV65Y
ZR6WdqV65YMay 9, 2019
Press Release

Neurodon Receives Funding from Elevate Ventures

Neurodon Receives Funding from Elevate Ventures Through the 21st Century Research & Technology Fund  …
ZR6WdqV65Y
ZR6WdqV65YJanuary 4, 2019
Press Release

Neurodon Awarded Phase I NIH STTR Grant

Neurodon Awarded Phase I NIH STTR Grant for Alzheimer’s Disease Drug Discovery Neurodon Corporation, an…
Colleen Mauger
Colleen MaugerSeptember 24, 2018
Press Release

Neurodon Scientists Have Validated a New Way to Halt Brain Cell Loss

PRLog -- Neurodon LLC, a leader in disease-modifying treatments for neurodegenerative diseases like Parkinson's, Alzheimer's, and…
ZR6WdqV65Y
ZR6WdqV65YFebruary 5, 2018
Press Release

Breakthrough Discovery for Parkinson’s Disease Treatment

Neurodon LLC has recently published a breakthrough study that paves the way for a new,…
ZR6WdqV65Y
ZR6WdqV65YOctober 14, 2016

Recent Posts

  • NIH grant to help fast-track Neurodon’s Alzheimer’s drug development research
  • New Scientific Advisory Board Member
  • Neurodon Welcomes Brunde Broady
  • SERCA Activator May Improve Memory and Cognition for Alzheimer’s Patients
  • Neurodon Receives Funding from Elevate Ventures

© 2021 Neurodon. All rights reserved. | Empowered by Digital Purpose | FCOI Policy

  • Home
  • Pipeline
  • Science
  • About
  • News
  • Contact